Ticagrelor

Function:
It is suitable for patients with acute coronary syndrome (ACS) or patients with a history of myocardial infarction and at least one high-risk factor for atherothrombotic events. It is used to reduce the incidence of cardiovascular death, myocardial infarction and stroke. It is often used to reduce the incidence of cardiovascular death, myocardial infarction and stroke. Use in conjunction with low-dose aspirin (75-100 mg).

Dosage:
Use in acute coronary syndrome Unless there are clear contraindications, ticagrelor should be used in combination with aspirin in patients with acute coronary syndrome. After taking the first dose of loading aspirin, the maintenance dose of aspirin is 75-100 mg once a day, and should not exceed 100 mg/d. The starting dose of ticagrelor is a single loading dose of 180 mg (90 mg × 2 tablets), followed by 1 tablet (90 mg) twice a day. Patients with a history of myocardial infarction For patients with a history of myocardial infarction for at least 1 year and who are associated with at least one high-risk factor for atherothrombotic events, when the patient requires long-term treatment, the recommended dosage is 60 mg twice daily. . For patients with ACS who are at high risk for atherothrombotic events, 60 mg of this product (2 doses daily) can be started immediately after 1 year of treatment with 90 mg of this product or other adenosine diphosphate (ADP) receptor inhibitors. times) continuous treatment; treatment with this product can also be started 2 years after myocardial infarction or within 1 year after stopping the previously taken ADP receptor inhibitor. Note: The treatment time of this product can be up to 12 months, unless there are clinical indications to stop the drug early. Stopping antiplatelet drug treatment prematurely may increase the risk of cardiovascular death or myocardial infarction caused by underlying diseases. Patients who cannot swallow the whole tablet can crush this product into fine powder, mix it with half a cup of water, and drink it immediately; then rinse the cup with half a cup of water and drink all the contents in the cup.

Adverse reactions:
Bleeding symptoms: gastrointestinal bleeding, gum bleeding, rectal bleeding, hematuria, guide bleeding, intraocular bleeding, nose bleeding, hemoptysis, etc. Dyspnea: It may manifest as mild to moderate dyspnea, and a few patients may have severe dyspnea due to bleeding. Increased uric acid: Patients taking ticagrelor long-term are at risk for increased uric acid. Bradycardia: Ticagrelor has the side effect of causing bradycardia, and in severe cases, bleeding, syncope, or loss of consciousness may occur. If any of the above adverse reactions occur, please inform your doctor or pharmacist in time.

Drug contraindications:
If allergic to this product, use with caution during lactation. Use with caution during pregnancy. Use with caution if liver function is impaired.